Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss Syndrome
Interventions
DRUG

NS-229

Experimental

DRUG

Placebo

Placebo comparator

Trial Locations (34)

15706

RECRUITING

Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela

19104

RECRUITING

University of Pennsylvania, Philadelphia

20145

RECRUITING

Istituto Auxologico Italiano IRCCS, Milan

29425

RECRUITING

Medical University of South Carolina, Charleston

31008

RECRUITING

Complejo Hospitalario de Navarra, Pamplona

31059

RECRUITING

Chu Rangueil, Toulouse

37126

RECRUITING

Azienda Ospedaliera Universitaria Integrata Verona, Verona

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

38122

RECRUITING

Azienda Provinciale per i Servizi Sanitari Provincia Autonoma Trento, Trento

43210

RECRUITING

The Ohio State University Wexner Medical Center, Columbus

44195

RECRUITING

Cleveland Clinic, Cleveland

55905

RECRUITING

Mayo Clinic, Rochester

73230

RECRUITING

Medius Kliniken gGmbh, Kirchheim unter Teck

75014

RECRUITING

Hopital Cochin, Paris

80206

RECRUITING

National Jewish Health, Denver

T6G 2B7

RECRUITING

University of Alberta, Edmonton

L8N4A6

RECRUITING

St Joseph's Healthcare Hamilton, Hamilton

M5G 1X5

RECRUITING

University of Toronto, Toronto

06202

RECRUITING

CHU Nice, Nice

00128

RECRUITING

Fondazione Policlinico Universitario Campus Bio-Medico, Roma

260-8677

RECRUITING

Chiba University Hospital, Chuo-ku, Chiba-shi

807-8555

RECRUITING

Hospital of the University of Occupational and Environmental Health, Japan, Kitakyushu

060-8648

RECRUITING

Hokkaido University Hospital, Sapporo

252-0392

RECRUITING

NHO Sagamihara National Hospital, Sagamihara

245-8575

RECRUITING

National Hospital Organization Yokohama Medical Center, Yokohama

980-8574

RECRUITING

Tohoku University Hospital, Sendai

583-8588

RECRUITING

Osaka Habikino Medical Center, Habikino

350-8550

RECRUITING

Saitama Medical Center, Kawagoe

113-8431

RECRUITING

Juntendo University Hospital, Bunkyo-ku

181-8611

RECRUITING

Kyorin University Hospital, Mitaka

143-8541

RECRUITING

Toho University Omori Medical Center, Ōta-ku

B15 2GW

RECRUITING

Queen Elizabeth Hospital Birmingham, Edgbaston

CB2 2QQ

RECRUITING

Addenbrookes Hospital, Cambridge

RG1 5AN

RECRUITING

Royal Berkshire NHS Foundation Trust, Reading

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Nippon Shinyaku Co., Ltd.

INDUSTRY

lead

NS Pharma, Inc.

INDUSTRY

NCT06046222 - Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis | Biotech Hunter | Biotech Hunter